Featured Research

from universities, journals, and other organizations

Asthma, Allergies May Reduce Risk Of Brain Cancer

Date:
July 15, 2005
Source:
Ohio State University
Summary:
Having asthma, hay fever or another allergic condition may reduce the risk of developing one fatal form of brain cancer, a new study suggests. New evidence for this relationship is found in the normal variation of two genes, the scientists say. Variations in certain genes may make a person more prone to develop asthma or allergies and those same variations may protect adults against the most common kind of brain cancer.

COLUMBUS , Ohio – Having asthma, hay fever or another allergic condition may reduce the risk of developing one fatal form of brain cancer, a new study suggests.

New evidence for this relationship is found in the normal variation of two genes, the scientists say.

“Variations in certain genes may make a person more prone to develop asthma or allergies and those same variations may protect adults against the most common kind of brain cancer,” said Judith Schwartzbaum, the study's lead author and an associate professor of public health at Ohio State University .

Glioblastoma multiforme (GBM) affects three out of 100,000 people, a rate that quadruples to 13 out 100,000 among people who are 65 and older. The average five-year survival rate from the time of diagnosis for GBM is only 3.3 percent, and is lower for people 65 and older.

The current study supports several years' worth of research by other scientists who have suggested an inverse relationship between asthma, allergies and GBM. But those studies were based only on information that participants gave about their history of asthma and allergies, not on information from DNA testing.

“We needed an objective way to measure the accuracy of allergy self reports, one that isn't affected by the presence of a brain tumor” Schwartzbaum said. “Looking at genetic variation is one way to do this.”

The study is the first to include a genetic component in addition to participant self-reports of asthma and allergy. The findings appear in the current issue of the journal Cancer Research.

The kind of genetic variant Schwartzbaum is talking about is called a polymorphism. While a mutation consists of a rare and abnormal DNA pattern, a polymorphism consists of common patterns, each considered normal.

Polymorphisms can offer protection against certain diseases or render a person more vulnerable to particular conditions. For example, researchers suspect that several polymorphic forms of key genes may increase susceptibility to Alzheimer's disease.

“People who have polymorphisms in the two genes that we examined may be susceptible to allergic conditions and may also have a lower risk of GBM,” Schwartzbaum said.

She and her colleagues analyzed DNA samples from 533 people, 111 of whom had been diagnosed with GBM. The other 422 randomly selected participants served as controls. All of the subjects were asked if they had ever been diagnosed with asthma, hay fever or eczema and, if so, how long each of these conditions had lasted.

The researchers looked for polymorphisms on two genes associated with asthma and allergies, IL-4RA and IL-13. In this study, individuals with one or two specific polymorphisms on the IL-4RA gene that increase asthma susceptibility seemed to have a lower GBM risk. The same was true for two polymorphisms on the IL-13 gene.

“Our results suggest that self-reports of asthma and allergy are a pretty accurate way to determine someone's susceptibility to this particular type of cancer,” Schwartzbaum said. “It's also important to realize that someone could have these asthma-susceptibility polymorphisms and never experience asthma or allergies.”

Schwartzbaum's next goal is to figure out the relationship between these allergy-inducing polymorphisms and GBM.

IL-4RA and IL-13 genes code for chemical messengers called cytokines, which control how immune system cells communicate and behave. Ironically, these cytokines may calm the immune system in the brain by helping to inhibit inflammation, even though they also eventually lead to increased inflammation in the lungs, which is a primary symptom of asthma.

It's possible, Schwartzbaum said, that the anti-inflammatory role of these cytokines may hinder tumor growth.

“I'm not sure if these cytokines play independent roles in both allergies and the development of brain tumors, if allergies and GBM share a common pathway in the immune system, or if it is allergies themselves that reduce GBM risk,” she said.

At any rate, having asthma or other allergic conditions may be somewhat beneficial.

Schwartzbaum conducted the study with researchers from Sweden , England and Wake Forest University in Wake Forest , North Carolina . The group received funding from the National Cancer Institute, the Swedish Council for Working Life and Social Research, the Swedish Cancer Society, the Swedish Research Council, the European Union Fifth Framework Program and the International Union Against Cancer.


Story Source:

The above story is based on materials provided by Ohio State University. Note: Materials may be edited for content and length.


Cite This Page:

Ohio State University. "Asthma, Allergies May Reduce Risk Of Brain Cancer." ScienceDaily. ScienceDaily, 15 July 2005. <www.sciencedaily.com/releases/2005/07/050715065710.htm>.
Ohio State University. (2005, July 15). Asthma, Allergies May Reduce Risk Of Brain Cancer. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2005/07/050715065710.htm
Ohio State University. "Asthma, Allergies May Reduce Risk Of Brain Cancer." ScienceDaily. www.sciencedaily.com/releases/2005/07/050715065710.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins